Global Health Limited (IN:MEDANTA)
:MEDANTA
MEDANTA Stock Chart & Stats
₹1216.65
₹16.70(1.57%)
At close: 4:00 PM EST
₹1216.65
₹16.70(1.57%)
Day’s Range― - ―
52-Week Range₹955.20 - ₹1,455.85
Previous CloseN/A
Volume335.07K
Average Volume (3M)17.50K
Market Cap
₹277.85B
Enterprise Value₹279.50B
Total Cash (Recent Filing)₹12.55B
Total Debt (Recent Filing)₹9.45B
Price to Earnings (P/E)83.8
Beta0.56
Next Earnings
May 15, 2026EPS Estimate
4.3Next Dividend Ex-DateN/A
Dividend Yield0.04%
Share Statistics
EPS (TTM)4.60
Shares Outstanding268,790,370
10 Day Avg. Volume39,597
30 Day Avg. Volume17,497
Financial Highlights & Ratios
PEG Ratio101.90
Price to Book (P/B)9.77
Price to Sales (P/S)9.09
P/FCF Ratio308.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,440.00Price Target Upside18.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)25.88
Revenue Forecast (FY)₹50.12B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth (12.7% year over year) indicates durable demand for tertiary/quaternary hospital services and expanding patient volumes or case mix. Over 2–6 months this underpins reinvestment capacity, supports margin maintenance and funds strategic expansion of specialties.
Strong Balance SheetLow leverage and a high equity ratio provide financial flexibility to fund capex, absorb demand shocks, and pursue selective expansions without heavy refinancing. A 14% ROE shows effective capital use, supporting long-term resilience and capacity to sustain investments in infrastructure.
Operating Cash GenerationConsistent operating cash flow coverage of net income reflects reliable cash conversion from hospital operations. This durable cash generation supports working capital, scheduled capex for equipment and beds, debt servicing and potential distributions without depending on volatile external funding.
Bears Say
Volatile Free Cash FlowA marked drop and volatility in free cash flow reduces predictability of internal funding for capex, expansion or payouts. Over the medium term this can force timing changes to investments, raise reliance on external financing in capex cycles, and increase execution risk.
Limited Strategic DisclosuresAbsence of disclosed corporate events or strategic updates limits investor visibility into growth plans, partnerships or M&A. Over a multi-month horizon this hampers assessment of management's execution roadmap and makes it harder to track durable initiatives that drive structural growth.
Minimal EPS GrowthEPS growth near 1.24% despite stronger revenue expansion suggests constrained earnings per share progression, possibly from margin pressure, dilution or higher costs. Persistently weak EPS growth can limit long-term shareholder return improvement even if revenues continue rising.
Global Health Limited News
MEDANTA FAQ
What was Global Health Limited’s price range in the past 12 months?
Global Health Limited lowest stock price was ₹955.20 and its highest was ₹1455.85 in the past 12 months.
What is Global Health Limited’s market cap?
Global Health Limited’s market cap is ₹277.85B.
When is Global Health Limited’s upcoming earnings report date?
Global Health Limited’s upcoming earnings report date is May 15, 2026 which is in 37 days.
How were Global Health Limited’s earnings last quarter?
Global Health Limited released its earnings results on Feb 04, 2026. The company reported ₹4.6 earnings per share for the quarter, missing the consensus estimate of ₹5.31 by -₹0.71.
Is Global Health Limited overvalued?
According to Wall Street analysts Global Health Limited’s price is currently Undervalued.
Does Global Health Limited pay dividends?
Global Health Limited pays a Notavailable dividend of ₹0.5 which represents an annual dividend yield of 0.04%. See more information on Global Health Limited dividends here
What is Global Health Limited’s EPS estimate?
Global Health Limited’s EPS estimate is 4.3.
How many shares outstanding does Global Health Limited have?
Global Health Limited has 268,790,370 shares outstanding.
What happened to Global Health Limited’s price movement after its last earnings report?
Global Health Limited reported an EPS of ₹4.6 in its last earnings report, missing expectations of ₹5.31. Following the earnings report the stock price went up 0.669%.
Which hedge fund is a major shareholder of Global Health Limited?
Currently, no hedge funds are holding shares in IN:MEDANTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Health Limited
Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. It operates a network of four hospitals in Gurugram, Indore, Ranchi, and Lucknow under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurgaon, India.
MEDANTA Stock 12 Month Forecast
Average Price Target
₹1,440.00
▲(18.36% Upside)
Technical Analysis
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Metropolis Healthcare Ltd.
―
Narayana Hrudayalaya Ltd.
―